Rare Tumors

Scope & Guideline

Innovating research for uncommon neoplasms.

Introduction

Immerse yourself in the scholarly insights of Rare Tumors with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN2036-3605
PublisherSAGE PUBLICATIONS LTD
Support Open AccessYes
CountryItaly
TypeJournal
Convergefrom 2010 to 2024
AbbreviationRARE TUMORS / Rare Tumors
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND

Aims and Scopes

The journal 'Rare Tumors' focuses on the publication of original research and case reports that delve into the unique characteristics, management strategies, and outcomes of rare tumors across various demographics. It aims to foster knowledge and understanding of less common malignancies, providing a platform for sharing clinical experiences that can influence treatment approaches and improve patient outcomes.
  1. Clinical Characteristics and Outcomes:
    The journal emphasizes the clinical presentation, characteristics, and treatment outcomes of rare tumors, providing insights that can guide clinical practice and improve patient management.
  2. Case Reports and Literature Reviews:
    A significant portion of the journal is dedicated to detailed case reports and literature reviews, which highlight unique and rare tumor presentations, diagnostic challenges, and therapeutic approaches.
  3. Multidisciplinary Approaches to Rare Tumors:
    The journal encourages discussions on multidisciplinary treatment strategies involving surgery, chemotherapy, radiation, and emerging therapies for managing rare tumors.
  4. Emerging Therapies and Innovations:
    It explores novel therapeutic options and advancements in the management of rare tumors, including the use of immunotherapies and targeted therapies.
  5. Global Perspectives on Rare Tumors:
    The journal features studies from various geographical locations, allowing for a broader understanding of rare tumors in diverse populations and healthcare settings.
Recent publications in 'Rare Tumors' have highlighted a number of trending and emerging themes that reflect the evolving landscape of rare tumor research. These themes indicate a shift towards more personalized medicine, innovative therapies, and comprehensive patient management strategies.
  1. Innovative Immunotherapies:
    There is a growing emphasis on the exploration of immunotherapy as a treatment modality for various rare tumors, reflecting a broader trend in oncology towards personalized and targeted treatment options.
  2. Psychosocial and Quality of Life Studies:
    Recent papers are increasingly addressing the psychosocial aspects and quality of life of patients with rare tumors, highlighting the importance of holistic patient care beyond just clinical outcomes.
  3. Multidisciplinary Treatment Approaches:
    The trend towards collaborative, multidisciplinary treatment strategies is evident, with more studies focusing on how combined efforts from different specialties can enhance patient outcomes for rare tumors.
  4. Genetic and Molecular Characterization:
    There is an emerging focus on the genetic and molecular profiling of rare tumors, contributing to a better understanding of tumor behavior and potential targeted therapies.
  5. Global Health Perspectives:
    An increase in studies that consider global health perspectives on rare tumors, including case reports from diverse geographical regions, is evident, promoting a more inclusive understanding of these malignancies.

Declining or Waning

While 'Rare Tumors' continues to focus on various aspects of rare malignancies, certain themes have shown a decline in prominence over recent years. These waning areas may reflect shifts in research priorities or the consolidation of knowledge in previously underexplored topics.
  1. General Tumor Biology Studies:
    There has been a noticeable decrease in publications focusing solely on the basic biology of rare tumors, as the journal shifts towards more clinically relevant case studies and treatment outcomes.
  2. Traditional Chemotherapy Protocols:
    The frequency of papers discussing traditional chemotherapy protocols for rare tumors is declining, possibly due to the rise of targeted therapies and immunotherapies that are gaining prominence in treatment discussions.
  3. Epidemiological Studies of Rare Tumors:
    Fewer epidemiological studies are being published, suggesting a waning interest in the statistical analysis of rare tumor incidence and prevalence, which may have been overshadowed by more pressing clinical insights and therapeutic innovations.

Similar Journals

Clinical Genitourinary Cancer

Advancing knowledge in genitourinary oncology.
Publisher: CIG MEDIA GROUP, LPISSN: 1558-7673Frequency: 6 issues/year

Clinical Genitourinary Cancer, published by CIG MEDIA GROUP, LP, is a leading journal in the fields of Oncology and Urology, with an impressive impact reflected in its quartile rankings (Q2 in Oncology and Q1 in Urology for 2023) and strong Scopus rankings (22nd in Urology and 162nd in Oncology). The journal aims to innovate and inspire new research in genitourinary malignancies, providing a platform for the latest findings in diagnosis, treatment, and patient management. With its commitment to high-quality publications since its establishment in 2005, Clinical Genitourinary Cancer serves a crucial role in advancing the understanding of these complex conditions and enhancing clinical practices. Researchers, professionals, and students in the medical community are encouraged to engage with this essential resource, which facilitates open access to pioneering studies that drive the field forward.

Case Reports in Nephrology and Dialysis

Advancing renal insights through shared experiences.
Publisher: KARGERISSN: 2296-9705Frequency: 3 issues/year

Case Reports in Nephrology and Dialysis, published by KARGER, is a vital peer-reviewed journal dedicated to the dissemination of case reports and innovative findings in the fields of nephrology and dialysis. Since its inception in 2015, this Open Access journal has aimed to foster knowledge exchange and improve patient outcomes through comprehensive case studies, clinical insights, and recent advancements in renal healthcare. Based in Switzerland, the journal is poised to serve a global audience, accommodating research that spans diverse geographical and clinical contexts. Currently ranked in the Q3 category for nephrology in 2023, it underscores its burgeoning influence in the medical literature, despite its relatively nascent presence. As a valuable resource for researchers, healthcare professionals, and students, it provides a platform for sharing unique cases that enrich the understanding of complex renal issues and challenges faced in dialysis. With an emphasis on high-quality, accessible research, Case Reports in Nephrology and Dialysis is committed to advancing nephrology and dialysis practices through collaboration and knowledge sharing.

Gastrointestinal Tumors

Fostering Global Collaboration in Gastrointestinal Studies
Publisher: KARGERISSN: 2296-3774Frequency: 4 issues/year

Gastrointestinal Tumors is a reputable, peer-reviewed journal dedicated to advancing knowledge in the field of gastrointestinal oncology. Published by KARGER, this journal has been a pivotal platform since its transition to Open Access in 2014, ensuring that research findings are accessible to a global audience of researchers, clinicians, and students engaged in this vital area of study. With an emphasis on innovative research, clinical studies, and comprehensive reviews, Gastrointestinal Tumors aims to bridge gaps in knowledge and foster discussions that will inform and enhance clinical practices. The journal's commitment to excellence reflects the rising importance of gastrointestinal health in medical research, making it an essential resource for anyone seeking to stay at the forefront of this rapidly evolving field. Based in Basel, Switzerland, it is positioned within a strong academic community, and continues to influence the landscape of gastrointestinal cancer research.

Intractable & Rare Diseases Research

Bridging Gaps in Rare Disease Knowledge.
Publisher: INT RESEARCH & COOPERATION ASSOC BIO & SOCIO-SCIENCES ADVANCEMENTISSN: 2186-3644Frequency: 4 issues/year

Intractable & Rare Diseases Research is a pioneering journal dedicated to advancing the understanding and treatment of rare and intractable diseases. Published by INT RESEARCH & COOPERATION ASSOC BIO & SOCIO-SCIENCES ADVANCEMENT in Japan, this esteemed journal serves as a critical platform for researchers, clinicians, and healthcare professionals to share groundbreaking findings and developments in the field. With its established Scopus ranking of #238 out of 636 in the General Medicine category, placing it in the 62nd percentile, and its classification in the Q3 quartile for 2023, it is recognized as a significant contributor to the literature on rare diseases. Operating without an open-access model, the journal ensures high-quality content cultivated through rigorous peer-review processes. Through its scope spanning from 2012 to 2024, the journal aspires to bridge gaps in knowledge and foster collaboration among interdisciplinary researchers, ultimately aiming to improve patient outcomes and enhance public health concerning these challenging conditions.

Case Reports in Oncology

Catalyzing Advances in Oncology Practice
Publisher: KARGERISSN: 1662-6575Frequency: 3 issues/year

Case Reports in Oncology is a peer-reviewed journal published by KARGER, dedicated to the dissemination of high-quality case studies and clinical reports in the field of oncology. Since its transition to Open Access in 2008, this Swiss-based journal has aimed to broaden the accessibility of key findings to a global audience of researchers, healthcare professionals, and students. The journal is positioned in the Q3 quartile for oncology, indicating its valuable contribution to the field, while also holding a Scopus rank of 294 out of 404 in Medicine, with a percentile of 27%. However, its open access model ensures that even those outside of traditional academic institutions can engage with critical advancements and novel insights from the oncology community. With a publication span extending from 2010 to 2024, Case Reports in Oncology serves as a crucial platform for sharing unique clinical experiences and innovative treatment strategies, ultimately enriching the practice and study of oncology.

Case Reports in Endocrinology

Pioneering case analyses for transformative endocrinology.
Publisher: HINDAWI LTDISSN: 2090-6501Frequency:

Case Reports in Endocrinology is a pioneering open access journal published by HINDAWI LTD, dedicated to advancing the field of endocrinology through the publication of case reports that illuminate the complexities of hormone-related disorders and metabolic issues. With its ISSN 2090-6501 and E-ISSN 2090-651X, the journal has been accessible since 2011, inviting contributions from researchers, clinicians, and students worldwide. Based in the United States, Case Reports in Endocrinology aims to disseminate critical insights and unique case analyses that contribute to the broader understanding of endocrinological conditions. While currently ranked Q4 in Endocrinology, Diabetes, and Metabolism, with Scopus placing it in the 29th percentile, the journal strives to enhance its impact and visibility. By fostering an environment for knowledge sharing and collaboration in a rapidly evolving field, this journal serves as an essential resource for those looking to deepen their understanding of endocrinological complexities and improve clinical practices.

Ocular Oncology and Pathology

Connecting Researchers for a Brighter Vision
Publisher: KARGERISSN: 2296-4681Frequency: 6 issues/year

Ocular Oncology and Pathology is a distinguished journal dedicated to the multifaceted study of ocular diseases, particularly focusing on oncology and pathology. Published by KARGER, a reputable publisher based in Switzerland, this journal serves as a vital resource for researchers, clinicians, and students in the fields of ophthalmology, pathology, and oncology. With an ISSN of 2296-4681 and an E-ISSN of 2296-4657, the journal has established itself as a significant contributor to the literature, achieving a commendable ranking of 55th out of 139 in the General Nursing category within Scopus, placing it in the 60th percentile. Now converging its expertise until 2024, Ocular Oncology and Pathology aims to publish high-quality, peer-reviewed research articles that advance the understanding of ocular neoplasms and their pathological features. The journal’s commitment to open access promotes the dissemination of vital scientific knowledge, ensuring worldwide accessibility to high-impact research, making it an essential platform for the academic community.

Internal Medicine

Unveiling the Nuances of Internal Medicine
Publisher: JAPAN SOC INTERNAL MEDICINEISSN: 0918-2918Frequency: 12 issues/year

Internal Medicine is a distinguished peer-reviewed journal published by the Japan Society of Internal Medicine, focusing on the nuanced field of internal medicine. Since its inception in 1974 and with a commitment to advancing medical knowledge, the journal has evolved remarkably, aiming to disseminate high-quality research that contributes to the understanding and treatment of internal diseases. Operating from Tokyo, Japan, it provides an intellectual platform for researchers and clinicians to publish original articles, reviews, and case studies that address various aspects of internal medicine. The journal currently holds a ranking in the Q3 quartile for both Internal Medicine and miscellaneous Medicine categories as of 2023, signifying its growing influence in the medical community. Although not an open-access journal, it remains accessible to a wide audience through institutional subscriptions, enhancing its reach among professionals and students alike. With its commitment to excellence, Internal Medicine serves as an essential resource for those seeking the latest developments and research within this vital medical field.

Archive of Clinical Cases

Innovative case studies shaping the future of clinical medicine.
Publisher: GRIGORE T POPA UNIV MEDICINE AND PHARMACY IASIISSN: Frequency: 4 issues/year

Archive of Clinical Cases is a premier journal dedicated to the dissemination of high-quality research in the field of clinical medicine and case studies. Published by GRIGORE T POPA UNIV MEDICINE AND PHARMACY IASI, this journal aims to bridge the gap between clinical practice and research, providing a platform for healthcare professionals, researchers, and students to share their findings and insights. With an emphasis on advancing medical knowledge through case reports, the journal plays a crucial role in enhancing evidence-based practices in clinical settings. Though the journal operates under an open-access model, its commitment to rigorous peer review ensures the integrity and quality of all published work. It invites contributions that contribute to the understanding of complex clinical scenarios, making it an invaluable resource for academics and practitioners alike. For those looking to expand their knowledge and stay abreast of the latest developments in clinical case reporting, the Archive of Clinical Cases is an indispensable addition to their academic journey.

BMJ Case Reports

Bridging Experience and Education in Medicine
Publisher: BMJ PUBLISHING GROUPISSN: Frequency: 1 issue/year

BMJ Case Reports is a vital resource within the field of medicine, published by the esteemed BMJ PUBLISHING GROUP. With an E-ISSN of 1757-790X and a focus on disseminating high-quality case reports, this journal serves as a platform for healthcare professionals, researchers, and students to share unique clinical experiences and uncommon presentations of medical conditions. Since its inception in 2008 and continuing through 2024, it has gained recognition for contributing to the advancement of medical knowledge, currently ranking at Q4 in the Medicine (miscellaneous) category and positioned in the 54th percentile in General Medicine according to Scopus rankings. Although it is a subscription-based journal, its impact on clinical practice and education is significant, enabling practitioners to learn from diverse case studies and improving patient care outcomes. As it aims to enhance the understanding of rare and significant medical cases, BMJ Case Reports remains an essential publication for those at the forefront of medical innovation.